For prescribing information, click here

This website has been commissioned by Ipsen Pharmaceuticals Ltd. and is intended for Irish Healthcare Professionals. If you are not a Healthcare Professional, please click here.
Adverse event reporting information is available at the bottom of this webpage.

This website has been commissioned by Ipsen Pharmaceuticals Ltd. and is intended for an Irish audience

Training Materials

Adult Spasticity

Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) therapeutic indications

Dysport® is indicated for symptomatic treatment of focal spasticity including:

  • Adult upper limbs
  • Adult ankle joint due to stroke or traumatic brain injury (TBI).
  • Please visit the PI link at the top of this page for the full list of indications.

Product Resources

BoNT type A mode of action video
BoNT type A mode of action video
Video 2:00

Watch this Mode of Action (MoA) video to see how botulinum toxin targets nerve signals to reduce muscle activity: delivering the therapeutic benefits of Dysport® with precision.

DYS-IE-000966 | August 2025

E-learning

AS US Essentials Introduction Video
AS US Essentials Introduction Video
Video 10:35

Injection training video on the use of ultrasound to identify and inject muscles of the upper and lower limb with Dysport® for treatment of adult focal spasticity.

DYS-IE-001017 | September 2025
AS US Essentials Injection of the Shoulder
AS US Essentials Injection of the Shoulder
Video 16:16

Injection training video on the use of ultrasound to identify and inject muscles of the shoulder with Dysport® for treatment of adult focal spasticity.

DYS-IE-001018 | September 2025
AS US Essentials Injection of the Elbow
AS US Essentials Injection of the Elbow
Video 13:40

Injection training video on the use of ultrasound to identify and inject muscles of the elbow with Dysport® for treatment of adult focal spasticity.

DYS-IE-000995 | September 2025
AS US Essentials Injection of the Forearm
AS US Essentials Injection of the Forearm
Video 11:20

Injection training video on the use of ultrasound to identify and inject muscles of the forearm with Dysport® for treatment of adult focal spasticity.

DYS-IE-000996 | September 2025
AS US Essentials Injection of the Hand
AS US Essentials Injection of the Hand
Video 13:20

Injection training video on the use of ultrasound to identify and inject muscles of the hand with Dysport® for treatment of adult focal spasticity.

DYS-IE-000997 | September 2025
AS US Essentials Injection of the Leg and Foot
AS US Essentials Injection of the Leg and Foot
Video 19:10

Injection training video on the use of ultrasound to identify and inject muscles of the leg and foot with Dysport® for treatment of adult focal spasticity.

DYS-IE-000998 | September 2025
Global Expert Insights: Dr. Jacinto on GAS
Global Expert Insights: Dr. Jacinto on GAS
Video 12:51

Dr. Jacinto’s expert presentation from the Ipsen Physio Webinar (Nov 2020) on Concepts and Practical Use of Goal Attainment Scaling (GAS) in managing adult spasticity.

DYS-IE-000999 | September 2025

Contact your Ipsen representative

Send request
Training Materials

Adverse events should be reported.
Reporting forms and information can be found at www.hpra.ie or e-mail medsafety@hpra.ie.
The HPRA can also be contacted on +353 16764971. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on +353 1 8098256.

To access relevant information about Adult Spasticity, please choose one of the following options:

I am a healthcare professional in Ireland

This section is for healthcare professionals only. Contains promotional information

I am a healthcare professional in Ireland

Adverse events should be reported.
Reporting forms and information can be found at www.hpra.ie or e-mail medsafety@hpra.ie.
The HPRA can also be contacted on +353 16764971. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on +353 1 8098256.

I am a patient

This section provides information to support patients that have been prescribed Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex).

I am a patient

I am a member of the general public

This section is for members of the general public.

I am a member of the general public

Reporting of side effects:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly to the HPRA. Reporting forms and information can be found at www.hpra.ie or email medsafety@hpra.ie. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on +353 1 8098256. By reporting side effects, you can help provide more information on the safety of this medicine.